STOCK MARKET BSE NSE

COVID-19: RDIF collabs with Panacea Biotec to produce 100 million doses of Sputnik V vaccine in India

Earlier last month, the RDIF and Hyderabad-based Virchow Biotech Private Limited inked an agreement to produce Sputnik V vaccine in India.

Published: 07th April 2021 12:37 PM  |   Last Updated: 07th April 2021 12:37 PM   |  A+A-

Russia's Sputnik V coronavirus vaccine arrives at Kosice Airport, Slovakia.

Russia's Sputnik V coronavirus vaccine (Photo | AP)

By ANI

NEW DELHI: One of India's largest vaccine and pharmaceutical company 'Panacea Biotec' in collaboration with the Russian Direct Investment Fund (RDIF) has agreed to produce 100 million doses per year of COVID-19 vaccine Sputnik V, the world's first registered vaccine against coronavirus.

According to a press release, Panacea Biotec Ltd (PBL) has announced that the Russian Direct Investment Fund (RDIF, Russia's sovereign wealth fund), and Panacea Biotec, one of the leading vaccine and pharmaceutical producers in India has agreed to cooperate to produce 100 million doses per year of Sputnik V.

Earlier last month, the RDIF and Hyderabad-based Virchow Biotech Private Limited inked an agreement to produce up to 200 million doses per year of Sputnik V vaccine (Russian made) in India.

Sputnik V has been registered in 54 countries globally with a total population of over 1.4 billion people. The efficacy of Sputnik V is 91.6 per cent as confirmed by the data published in the Lancet, one of the world's oldest and most respected medical journals.



Comments

Disclaimer : We respect your thoughts and views! But we need to be judicious while moderating your comments. All the comments will be moderated by the newindianexpress.com editorial. Abstain from posting comments that are obscene, defamatory or inflammatory, and do not indulge in personal attacks. Try to avoid outside hyperlinks inside the comment. Help us delete comments that do not follow these guidelines.

The views expressed in comments published on newindianexpress.com are those of the comment writers alone. They do not represent the views or opinions of newindianexpress.com or its staff, nor do they represent the views or opinions of The New Indian Express Group, or any entity of, or affiliated with, The New Indian Express Group. newindianexpress.com reserves the right to take any or all comments down at any time.

flipboard facebook twitter whatsapp